HUP0004282A2 - 2-Halogén-6-0-szubsztituált ketolidszármazékok - Google Patents

2-Halogén-6-0-szubsztituált ketolidszármazékok

Info

Publication number
HUP0004282A2
HUP0004282A2 HU0004282A HUP0004282A HUP0004282A2 HU P0004282 A2 HUP0004282 A2 HU P0004282A2 HU 0004282 A HU0004282 A HU 0004282A HU P0004282 A HUP0004282 A HU P0004282A HU P0004282 A2 HUP0004282 A2 HU P0004282A2
Authority
HU
Hungary
Prior art keywords
halo
ketolide derivatives
substituted ketolide
compounds
pharmaceutically acceptable
Prior art date
Application number
HU0004282A
Other languages
English (en)
Inventor
Yan Chen
Daniel T. Chu
Richard F. Clark
Yat Sun Or
Ly Tam Phan
Jacob J. Plattner
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of HUP0004282A2 publication Critical patent/HUP0004282A2/hu
Publication of HUP0004282A3 publication Critical patent/HUP0004282A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

A találmány (I) és (II) általános képletű új 2-halogén-6-O-szubsztituált ketolidszármazékokra és azok gyógyszerészetilegelfogadható sóira és észtereire vonatkozik, amelyek antibakteriálisaktivitással rendelkeznek. A találmány tárgykörébe tartoznak továbbá avegyületek előállítására szolgáló eljárások, valamint agyógyszerészetileg elfogadható hordozó mellett a vegyületek terápiásanhatékony mennyiségét tartalmazó gyógyszerkészítmények, amelyek emlősökbakteriális fertőzés elleni kezelésére alkalmazhatók. Ó
HU0004282A 1997-10-29 1998-10-29 2-halo-6-0-substituted ketolide derivatives HUP0004282A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US95988197A 1997-10-29 1997-10-29
US15423998A 1998-09-16 1998-09-16
PCT/US1998/022989 WO1999021871A1 (en) 1997-10-29 1998-10-29 2-halo-6-o-substituted ketolide derivatives

Publications (2)

Publication Number Publication Date
HUP0004282A2 true HUP0004282A2 (hu) 2001-04-28
HUP0004282A3 HUP0004282A3 (en) 2001-10-29

Family

ID=26851273

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0004282A HUP0004282A3 (en) 1997-10-29 1998-10-29 2-halo-6-0-substituted ketolide derivatives

Country Status (25)

Country Link
EP (1) EP1027362B1 (hu)
JP (1) JP2001521039A (hu)
KR (1) KR100536420B1 (hu)
CN (1) CN1240707C (hu)
AR (1) AR015994A1 (hu)
AT (1) ATE298760T1 (hu)
AU (1) AU751448B2 (hu)
BG (1) BG64707B1 (hu)
BR (1) BR9813319A (hu)
CA (1) CA2307788C (hu)
CO (1) CO4990960A1 (hu)
CZ (1) CZ300063B6 (hu)
DE (1) DE69830739T2 (hu)
DK (1) DK1027362T3 (hu)
ES (1) ES2244094T3 (hu)
HK (1) HK1031383A1 (hu)
HU (1) HUP0004282A3 (hu)
IL (1) IL135519A0 (hu)
NO (1) NO20002190L (hu)
NZ (1) NZ503822A (hu)
PL (1) PL191453B1 (hu)
PT (1) PT1027362E (hu)
SK (1) SK286397B6 (hu)
TR (1) TR200001142T2 (hu)
WO (1) WO1999021871A1 (hu)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39743E1 (en) * 1998-10-15 2007-07-24 Aventis Pharma S.A. 2-halogenated derivatives of 5-0 desosaminyl-erythronolide a, their preparation process and their antibiotic use
FR2784682B1 (fr) * 1998-10-15 2002-12-06 Hoechst Marion Roussel Inc Nouveaux derives 2-halogene de 5-0-desosaminylerythronolide a, leur procede de preparation et leur application comme medicaments
US6451768B1 (en) 1999-04-16 2002-09-17 Kosan Biosciences, Inc. Macrolide antiinfective agents
US6939861B2 (en) 1999-04-16 2005-09-06 Kosan Biosciences, Inc. Amido macrolides
ATE340183T1 (de) 1999-04-16 2006-10-15 Kosan Biosciences Inc Antiinfektiöse makrolidderivate
US6514944B2 (en) 1999-04-16 2003-02-04 Kosan Biosciences, Inc. Macrolide antiinfective agents
ES2306674T3 (es) * 1999-12-02 2008-11-16 Abbott Laboratories Derivados cetolidos 6-o-alquil-2-nor-2-sustituidos.
US6569836B2 (en) 1999-12-02 2003-05-27 Abbott Laboratories 6-O-alkyl-2-nor-2-substituted ketolide derivatives
JP2001261694A (ja) 2000-03-06 2001-09-26 Pfizer Prod Inc ケトライド抗生物質
US6605707B1 (en) * 2000-03-23 2003-08-12 Abbott Laboratories Process for the preparation of 6-O-propargyl erythromycin derivatives
EP1167376B1 (en) 2000-06-30 2004-07-14 Pfizer Products Inc. Macrolide antibiotics
US6472372B1 (en) * 2000-12-06 2002-10-29 Ortho-Mcneil Pharmaceuticals, Inc. 6-O-Carbamoyl ketolide antibacterials
CN1589277A (zh) 2001-09-17 2005-03-02 奥索-麦克尼尔药品公司 6－o－氨基甲酸酯－11,12－内酯－酮内酯抗菌剂
US6825170B2 (en) 2001-12-05 2004-11-30 Ortho-Mcneil Pharmaceutical, Inc. 6-O-acyl ketolide antibacterials
MXPA04007883A (es) * 2002-02-13 2004-11-26 Abbott Lab Compuestos antimicrobianos de macrolido.
WO2003090760A1 (en) * 2002-04-25 2003-11-06 Abbott Laboratories Oxolide antibacterials
WO2003090761A1 (en) * 2002-04-25 2003-11-06 Abbott Laboratories 9-oxime macrolide antibacterials
WO2004078771A1 (ja) * 2003-03-07 2004-09-16 Taisho Pharmaceutical Co., Ltd. ２－フルオロ－６－ｏ－置換ケトライド誘導体
JP2007254285A (ja) * 2004-03-16 2007-10-04 Taisho Pharmaceut Co Ltd ２−フルオロ−６−ｏ−置換ケトライド誘導体
KR101566053B1 (ko) * 2009-05-27 2015-11-04 욱크하르트 리미티드 항균 활성을 갖는 케톨라이드

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of the history of erythromycin
ATE145212T1 (de) * 1992-04-22 1996-11-15 Taisho Pharmaceutical Co Ltd 5-0-desosaminylerythronolide a derivate
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
CZ20001525A3 (cs) 2000-10-11
KR20010015793A (ko) 2001-02-26
WO1999021871A1 (en) 1999-05-06
BG104434A (en) 2001-01-31
DE69830739D1 (de) 2005-08-04
NO20002190L (no) 2000-06-29
CZ300063B6 (cs) 2009-01-21
HUP0004282A3 (en) 2001-10-29
TR200001142T2 (tr) 2000-09-21
NO20002190D0 (no) 2000-04-27
DK1027362T3 (da) 2005-10-31
CN1283199A (zh) 2001-02-07
PL340290A1 (en) 2001-01-29
SK286397B6 (sk) 2008-09-05
ATE298760T1 (de) 2005-07-15
PT1027362E (pt) 2005-08-31
NZ503822A (en) 2002-12-20
ES2244094T3 (es) 2005-12-01
EP1027362B1 (en) 2005-06-29
CO4990960A1 (es) 2000-12-26
SK6332000A3 (en) 2000-09-12
KR100536420B1 (ko) 2005-12-16
DE69830739T2 (de) 2006-04-20
BR9813319A (pt) 2000-08-22
CA2307788C (en) 2008-05-20
CA2307788A1 (en) 1999-05-06
PL191453B1 (pl) 2006-05-31
JP2001521039A (ja) 2001-11-06
AU751448B2 (en) 2002-08-15
AR015994A1 (es) 2001-05-30
CN1240707C (zh) 2006-02-08
HK1031383A1 (en) 2001-06-15
AU1288199A (en) 1999-05-17
IL135519A0 (en) 2001-05-20
BG64707B1 (bg) 2005-12-30
EP1027362A1 (en) 2000-08-16

Similar Documents

Publication Publication Date Title
HUP0004282A2 (hu) 2-Halogén-6-0-szubsztituált ketolidszármazékok
BG103945A (en) Derivatives of 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a
TR199901127T2 (xx) Antibakteriyel etkili 6-O-ikameli ketolitler.
AP9801378A0 (en) 9-amino-3- keto erythromycin derivatives.
MX9707453A (es) Derivados de quinazolina.
SE9504661D0 (sv) New compounds
PT915898E (pt) Forma i cristalina de claritromicina
BG101118A (en) Therapeutical compounds
AP9801253A0 (en) 9-Oxime erythromycin derivatives.
AR019496A1 (es) Azalidas de 13 miembros, composiciones farmaceuticas, uso en la preparacion de medicamentos y preparacion de los mismos
ES2173858T3 (es) Analogos de huperzina a.
HUP0003571A2 (hu) 6,9-Hídkötésű eritromicin-származékok
DK1057828T3 (da) Orale trovafloxacin-suspensioner
HUP0102903A2 (hu) Nokatiacin antibiotikumok, eljárás az előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények
BR9814498A (pt) Processo para o tratamento de obesidade em um humano necessitando de tal tratamento, composto, uso do mesmo, produto, e, composição farmacêutica
DE69819539D1 (de) Antithrombotische mittel
ATE310010T1 (de) 6-0-substitutierte eryththromycin-verbindungen und verfahrenen zu ihrer herstellung
SE9504662D0 (sv) New compounds
DE69828522D1 (de) Antithrombotische mittel
AP9801235A0 (en) Erythromycin derivatives.
TR200003451T2 (tr) Pirimidin-Aminometil-Piridin Türevleri, Hazırlanmaları ve helikobakter bakterinin kontrolünde kullanımları
DK0742716T3 (da) Farmaceutisk sammensætning til systemisk transdermal indgivelse med det aktive middel morphin-6-glucuronid
PT1232173E (pt) Derivados do acido fusidico
AU1434201A (en) Antithrombotic agents
BG103985A (en) Multicyclic derivatives of erythromycin

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees